Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2026-01-03 @ 9:22 PM
Study NCT ID:
NCT03825367
Status:
UNKNOWN
Last Update Posted:
2022-10-12
First Post:
2019-01-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML
Sponsor:
Therapeutic Advances in Childhood Leukemia Consortium
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-11-29
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-03-30
Completion Date Type:
ESTIMATED
First Submit Date:
2019-01-28
First Submit QC Date:
None
Study First Post Date:
2019-01-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-10
Last Update Post Date:
2022-10-12
Last Update Post Date Type:
ACTUAL